Preventive Strategies against Bleeding due to Nonvitamin K Antagonist Oral Anticoagulants

Dabigatran etexilate (DE), rivaroxaban, and apixaban are nonvitamin K antagonist oral anticoagulants (NOACs) that have been compared in clinical trials with existing anticoagulants (warfarin and enoxaparin) in several indications for the prevention and treatment of thrombotic events. All NOACs prese...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Sarah, Lessire, Anne-Sophie, Dincq, Jonathan, Douxfils, Bérangère, Devalet, Jean-Baptiste, Nicolas, Anne, Spinewine, Anne-Sophie, Larock, Jean-Michel, Dogné, Maximilien, Gourdin, François, Mullier
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Hindawi Publishing Corporation 2014
Konular:
Review Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4084591/
https://ncbi.nlm.nih.gov/pubmed/25032218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/616405
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller